BCM
GH icon

BlueCrest Capital Management’s Guardant Health GH Stock Holding History

BlueCrest Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,813
Closed -$363K – 651
2020
Q4 		$363K Buy
+2,813
New +$324K 0.01% 337

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BlueCrest Capital Management's GH Position: Q1 2021 in Review

BlueCrest Capital Management sold out of Guardant Health (GH) in Q1 2021, closing a stake of 2,813 shares — an estimated $363K sold.

BlueCrest Capital Management first reported a position in GH in Q4 2020 and held it in 1 quarter. The position peaked at $363K in Q4 2020. 419 funds tracked by Wall St. Rank hold GH as of Q1 2021.

  • BlueCrest Capital Management reported no remaining Guardant Health position as of Q1 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,813 Guardant Health shares in Q1 2021, an estimated $363K.
  • BlueCrest Capital Management first reported a position in Guardant Health in Q4 2020 and held it in 1 quarter.
  • BlueCrest Capital Management's Guardant Health position peaked at $363K in Q4 2020.
  • 419 funds tracked by Wall St. Rank held Guardant Health as of Q1 2021.

Based on BlueCrest Capital Management's 13F filing for Q1 2021, filed 17 May 2021.